Cite

HARVARD Citation

    Mareckova, A. et al. (2019). ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. Leukemia & lymphoma. 60 (6), pp. 1420-1428. [Online]. 
  
Back to record